Tuesday, 22 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Finance
Clinical trial results
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14455
Articles
Company
Deals
Formosa Pharmaceuticals Strikes Licensing Deal with Cristália for Ocular Surgery Pain Treatment in Brazil
October 24, 2024
Company
Lonza Announces Factory Closures in the US and China Amid Global Network Optimization
October 24, 2024
Company
Policy / Regulatory
China-Based Biotechs Respond to US House Bill Limiting Federal Funding for ‘Concerning’ Companies
October 24, 2024
Company
Drug
Eisai’s Alzheimer’s Drug Leqembi Earns Marketing Approval in China
October 28, 2024
Company
Deals
Wuxi National Hi-Tech District Welcomes Synthetic Biology Industrial Park and East China’s First R&D Center
October 25, 2024
Company
Deals
Kingmed Diagnostics and MegaRobo Technologies Join Forces to Pioneer Smart Medical Laboratories
October 25, 2024
Company
Drug
Henlius Biotech Ships First International Batch of HanSiZhuang for Cancer Treatment to Indonesia
October 25, 2024
Company
Drug
Shanghai Fosun Pharmaceutical Receives NMPA Approval for Phase II Study of FCN-338 for Light Chain Amyloidosis
October 25, 2024
Company
Deals
MSD Partners with Variational AI to Harness Generative AI for Drug Discovery
December 10, 2024
Company
Drug
Gan & Lee Pharmaceuticals Receives Bolivian Approval for Insulin Aspart, Expanding Access to Rapid-Acting Insulin
October 25, 2024
Policy / Regulatory
China’s NHC Designates 100 Areas as National Demonstration Zones for Integrated Medical and Elderly Care
October 25, 2024
Company
Drug
Roche Commences Phase II Trial of Repare Therapeutics’ ATR Inhibitor, Camonsertib, in Solid Tumors
October 25, 2024
1
2
…
775
776
777
778
779
…
1,204
1,205
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?